Drug Trial to Investigate the Safety and Efficacy of Niclosamide Tablets in Patients With Metastases of a Colorectal Cancer Progressing After Therapy

PHASE2UnknownINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

December 31, 2019

Study Completion Date

August 31, 2020

Conditions
Colorectal Cancer
Interventions
DRUG

Niclosamide

2 g per day orally

Trial Locations (1)

10117

RECRUITING

Charité Universitätsmedizin Berlin; Charité Comprehensive Cancer Center, Berlin

Sponsors
All Listed Sponsors
collaborator

Center for Molecular Medicine

OTHER

lead

Charite University, Berlin, Germany

OTHER